# Amneal Pharmaceuticals, Inc.: Form 8-K, filed Jan 15, 2025

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: 8-K
- Filed: 2025-01-15
- Accepted by EDGAR: Jan 15, 2025, 06:14 ET
- Period: 2025-01-15
- Accession: 0001723128-25-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000172312825000005/amrx-20250115.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000172312825000005/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000172312825000005/amrx-20250115.htm

Filed Jan 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001723128-25-000005. Last ingested by Listed: Nov 10, 2026, 02:45 ET. No prices; not investment advice.